The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Isomorphic Labs launches into an already well-populated drug discovery category, with many large drugmakers exploring the technology along with a host of specialist players like Exscientia ...

Isomorphic Labs aims to start clinical trials for AI-designed drugs by year-end, potentially revolutionizing drug discovery timelines. Market optimism persists under Trump 2.0, with a focus on big ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. Isomorphic is ...

Marshall was adding some color to the pharma giant’s then-new collaboration with Isomorphic Labs, the DeepMind spin-off launched in 2021 by Demis Hassabis, coinventor of the protein-folding ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against the other AI stocks. AI is ...